Abstract:Aim: Recombiant human telomerase reverse transcriptase (hTERT)-human IL-18(hIL18) was constructed to investigate its expression and biological function in eukaryotic cells. DCs transfected with hTERT-IL18 acquired stronger telomerase activity and were able to elicit an hTERT-specific cytotoxic T lymphocyte CTL response in vitro.Methods: hIL-18 gene fragment was amplified by Polymerase chain reaction (PCR) and TA cloned. The hIL18 gene was then subcloned into eukaryotic expression vector pcDNA3.1(+) containing human TERM via a linker. The sequence of gene fusion was confirmed using both restrictive enzyme digestion and DNA sequencer. The expression vector with gene fusion was transfected into 3T3 cell line with Lipofectamine 2000. ELISA, Western blot, immunofluorescence stain were performed to determine the expression properties of hTERT-hIL18 in 3T3 cells. Its biological effect on the anti-apoptosis was measured by Flow cytometry and its effect on INF-gamma expression was determined using ELISA. After preparation of dendritic cells, hTERT-hIL18, hTERT, hIL-18 expression vectors were transfected into DCs respectively by electroporation to generate hTERT-specific DCs lines. The peripheral blood mononuclear cells PBMCs were stimulated with different DCs lines to create specific CTL. The response of target cell (leukemia cell line-K562 cell) to hTERT-specific CTL was evaluated by LDH release assay.Results: The human IL-18 gene fragment was amplified from the human mononuclear cells and was inserted into pcDNA3.1(+)/hTERT vector successfully. The correct sequence was proved by both restrictive enzyme digestion and sequencing. The correct open reading frame was also verified. Fusion protein of hTERT-hIL18 was effectively expressed in eukaryotic cells, which was detected by both Western-blotting and immunofluorescence stain. The expressed recombinant fusion protein induced similar levels of INF-gamma to that of native IL-18 protein. FCM assay showed that the transfected fusion protein inhibited the apoptosis, which was consistent with the effects of hTERT as a universal tumor associated antigen. CTL assay shows that hTERT-hIL18 and hTERT gene-transfected DCs stimulated T-cell responses that recognized and lysed tumor target cells of high hTERT expression, whereas DCs transfected with hIL-18 gene didn't induced the response of tumor targets lyses.Conclusion: The Recombinant hTERT-hIL18 fusion protein had both biological activity of hTERT and hIL-18, indicating that this rationally designed protein can be further developed as novel tumor therapeutics. DCs transfected with hTERT-IL18 gene were capable of eliciting a stronger hTERT-specific CTL response in vitro.

[Immunization with Dendritic Cells Infected with Mtert Adenovirus Vector Effectively Elicits Immunity Against Mouse H22 Hepatoma in Vivo].

Induction of specific CTL elicited by dendritic cells transfected with recombinant adenovirus vector expressing the mouse telomerase reverse transcriptase in vitro

Antitumor Effect of Immunizations with Fusions of Dendritic and Hepatocellular Carcinoma Cells in Mice

Therapeutic Effect of MIP-1alpha-recruited Dendritic Cells on Preestablished Solid and Metastatic Tumors.

Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.

In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus.

[Immunization with Dendritic Cells Infected with Human AFP Adenovirus Vector Effectively Elicits Immunity Against Mouse Hepatocellular Carcinomas].

Antitumor Effect of Immunization with Fusion of Dendritic Cells and Hepatocellular Carcinoma Cells in Mice.

Recombinant adenovirus of SEA and CD80 genes driven by MMRE and mouse TERT promoter induce effective antitumor immune responses against different types of tumor cells in vitro and in vivo

Study on the Immune Response Induced by Hbcag Gene-Modified Dendritic Cells in Hepatitis B Virus Transgenic Mice

Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.

Construction of Expression Vector of Htert- Hil18 Fusion Gene and Induction of Cytotoxic T Lymphocyte Response Against Htert.

Inhibition of Hepatocellular Carcinoma Growth by Adenovirus-Mediated Expression of Human Telomerase Reverse Transcriptase Cooh-27 Terminal Polypeptide in Mice

GENETICALLY MODIFIED DENDRITIC CELLS INDUCED SPECIFIC CYTOTOXITY AGAINST HUMAN HCC CELLS IN VITRO

Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells

Enhanced Antitumor Effect Against Human Telomerase Reverse Transcriptase (Htert) By Vaccination With Chemotactic-Htert Gene-Modified Tumor Cell And The Combination With Anti-4-1bb Monoclonal Antibodies

Overexpression of the Mtert Gene by Adenoviral Vectors Promotes the Proliferation of Neuronal Stem Cells in Vitro and Stimulates Neurogenesis in the Hippocampus of Mice

[Immunological Killing Effect of Recombicant Adenovirus Vector Rad-Mtert-m4-1bbl on Mouse Hepatoma Cell Line Hepa1-6 Cells Co-Cultured with T Lymphocytes].

[Study of the Cytotoxity Against Human Hepatocellular Carcinoma Cells Induced by the MAGE-1 Gene Modified Dendritic Cells].

In Vitro Anti-Tumor Immune Response Induced by Dendritic Cells Transfected with Recombinant Adenovirus Carrying Mutant K-Ras Genes

Therapeutic effects of recombinant adenovirus expressing fusion peptide NT4p53(N15)Ant on mice bearing transplanted liver cancer